One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.

EuroIntervention 2006;2:69-76 - DOI10.4244/EIJV2I1A12.

Carlos Macaya1, MD; Héctor M. García-García2, MD; Antonio Colombo3, MD; Marie-Claude Morice4, MD; Victor Legrand5, MD; Karl-Heinz Kuck6, MD; Imad Sheiban7, MD; Maarten Jan Suttorp8, MD; Didier Carrie9, MD; Mathias Vrolix10, MD; Kristel Wittebols11, MSc; Hans-Peter Stoll11, MD; Dennis Donohoe12, MD; Marco Bressers13, MSc; Patrick W. Serruys2*, MD, PhD

1. Hospital Clinico St. Carlos, Madrid, Spain; 2. Erasmus Medical Center, Rotterdam, The Netherlands; 3. San Raffaelle Hospital, Milan, Italy; 4. Institute Cardiovasculaire Paris Sud, Massy, France; 5. CHU Liege Sart Tilman, Liege, Belgium; 6. AK St. Geor

Background: ARTS-II was designed to evaluate the sirolimus-eluting stent (SES) versus ARTS-I. The objective of this analysis is to assess the safety and efficacy of the SES in diabetic pati

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

stentsrevascularizationdiabetes mellitus

Share on Facebook Share on Twitter Share on Linkedin

One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.

Read next article

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke